Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
Phase 2
Completed
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Interventions
- Drug: Placebo to match NRD135S.E1
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Novaremed Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT02345291
- Locations
- 🇮🇱
Diabetes and Endocrinology clinic, Bat-Yamon Medical center, Clalit health services, Bat-Yam, Israel
🇮🇱Diabetes clinic, Lin Medical Center, Haifa, Israel
🇮🇱Rambam Medical Center, Diabetic Endocrine unit, Haifa, Israel
News
No news found